StockData
Skye Bioscience, Inc. logo

Skye Bioscience, Inc. (SKYE) bonds

SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$1.06−0.03 (-2.29%)

Close on Nov 16, 2026Market cap $37.72MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Skye Bioscience reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Skye Bioscience's 10-K for the period ended Dec 31, 2024

Skye Bioscience's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Convertible 10% Note$5.00M

See a number that looks wrong?